Aptamer-Directed Conjugation of DNA to Therapeutic Antibodies

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

A method for aptamer directed conjugation of DNA to therapeutic antibodies has been developed. In the method, an antibody selective aptamer binds to a specific site in the constant domain of human IgG1 antibodies and is used for both templated and direct conjugation to the antibodies. Through optimization of the design and reaction conditions, the antibody-DNA conjugates could be produced efficiently using equal stoichiometry of protein and DNA. Three different antibodies were evaluated, and the conjugates were characterized by anion exchange chromatography and SDS-PAGE. The conjugation sites for one of the antibodies were determined by MS/MS analysis of the digested conjugate. The antibody-DNA conjugate was also tested for receptor binding on cell surfaces showing retained binding.

OriginalsprogEngelsk
TidsskriftBioconjugate Chemistry
Vol/bind30
Nummer8
Sider (fra-til)2127-2135
Antal sider9
ISSN1043-1802
DOI
StatusUdgivet - 2019

Se relationer på Aarhus Universitet Citationsformater

ID: 167040453